THW (Tekla World Healthcare Fund) Risk Assessment


THW Tekla World Healthcare Fund THW
57 GF Score
Price $13.65
GF Value $19.36
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tekla World Healthcare Fund Risk Assessment?

Risk Assessment represents the investment risk of a stock derived from our exclusive method. It suggests how risky the investment opportunity is based on the valuation and the fundamental performance of the stock. It is derived from following key aspects:

1. GuruFocus internally developed valuations of the stock, such as GF valuation.
2. Quality Rank, a business quality indicator developed by GuruFocus.
3. Fundamental performance: Piotroski F-Score, Altman Z-Score, Beneish M-Score, etc.
4. Growth opportunities: 5-year revenue growth rate, 5-Year EPS without NRI Growth Rate, etc.

Value investors are always willing to find undervalued stocks. However, not all the undervalued stocks are good deals, we should also be careful of how risky the investment opportunity is. We believe that if the company's financial strength and profitability are strong, and the stock price is within a reasonable range of the GF valuation, or stock has a high return with its price being undervalued, then it might be a good investment opportunity with low risk.

Based on those aspects listed above, GuruFocus believes the risk assessment of Tekla World Healthcare Fund is: No Data: Cannot be evaluated.

Tekla World Healthcare Fund  (NYSE:THW) Risk Assessment Explanation

Based on the four aspects listed above, GuruFocus provides the following 7 evaluations:

All-in-One Screener Examples (1)
Low Risk: Strong fundamentals, worth long-term holding
Moderate Risk: Sensitive, better choose undervalued stock
High Risk: High uncertainty with risk-return tradeoff
High Risk: Good fundamentals, beware of shrinking business
High Risk: Sensitive to economic or industry trends
High Risk: High uncertainty
No Data: Cannot be evaluated

(1) These are some simple examples. You can access our Risk Assessment filter under All-in-One Screener’s Fundamental tab and set your own criteria.

Tekla World Healthcare Fund Risk Assessment Related Terms

THW vs MSIF, IQI, TWN: Risk Assessment Comparison

For the Asset Management subindustry, Tekla World Healthcare Fund's Risk Assessment, along with its competitors' market caps and Risk Assessment data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Tekla World Healthcare Fund Risk Assessment vs Asset Management Industry

For the Asset Management industry and Financial Services sector, Tekla World Healthcare Fund's Risk Assessment distribution charts can be found below:

* The bar in red indicates where Tekla World Healthcare Fund's Risk Assessment falls into.


THW
57GF Score
Tekla World Healthcare Fund THW
Risk Assessment is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tekla World Healthcare Fund (THW) Overvalued in 2026?

Based on GuruFocus' analysis, Tekla World Healthcare Fund stock appears to be undervalued. The current stock price of $13.65 is trading 29.5% below its estimated GF Value™ of $19.36. GuruFocus considers Tekla World Healthcare Fund to be Modestly Undervalued.

Key valuation signals for THW:

  • Risk Assessment:
  • GF Value™: $19.36 vs. price of $13.65 (29.5% below fair value)
  • GF Score™: 57/100 with 6 warning signs

No single metric tells the full story. See the THW stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Tekla World Healthcare Fund Business Description

Address 1900 Market Street, Suite 200, Philadelphia, PA, USA, 19103
Tekla World Healthcare Fund is a diversified closed-end management investment company. Its investment objective is to seek current income and long-term capital appreciation. The Fund mainly invests in equity and debt securities of public and private U.S. and non-U.S. companies that the Fund's investment adviser believes have the potential for above-average growth. The company's investment portfolio includes holdings across various sub-sectors such as pharmaceuticals and biotechnology, healthcare providers and services, real estate investment trusts, medical devices and diagnostics, and other related areas.
57GF Score

Get the complete analysis for THW

Risk Assessment is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.65
Price
$19.36
GF Value